We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295

Top Buys

Rank Stock Value
1
JWSM
Jaws Mustang Acquisition Corp.
JWSM
+$52.5M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29.9M
3
AAC
Ares Acquisition Corporation
AAC
+$29.8M
4
FCAX
Fortress Capital Acquisition Corp.
FCAX
+$21.5M
5
SVFA
SVF Investment Corp. Class A Ordinary Shares
SVFA
+$21M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$187M
2
AVLR
Avalara, Inc.
AVLR
+$149M
3
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$112M
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$96.2M
5
ZEN
ZENDESK INC
ZEN
+$91M

Sector Composition

Rank Sector Weight
1 Financials 69.3%
2 Technology 10.26%
3 Industrials 8.47%
4 Healthcare 5.73%
5 Real Estate 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRECU
451
DELISTED
Crescera Capital Acquisition Corp Unit
CRECU
$33K ﹤0.01%
3,200
+700
+28% +$7.11K
GSQB.U
452
DELISTED
G Squared Ascend II Inc. Units, each consisting of one Class A ordinary share and one-third of a redeemable Warrant to acquire one Class A ordinary shares
GSQB.U
$31K ﹤0.01%
+3,051
New +$30.7K
KSICU
453
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$30K ﹤0.01%
2,979
– –
WTMAU
454
DELISTED
Welsbach Technology Metals Acquisition Corp. Unit
WTMAU
$29K ﹤0.01%
2,858
– –
SUAC.U
455
DELISTED
ShoulderUp Technology Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
SUAC.U
$28K ﹤0.01%
2,770
– –
ADRT.U
456
DELISTED
Ault Disruptive Technologies Corporation Units, each consisting of one share of Common Stock, and three-fourths of one Redeemable Warrant to purchase one share of Common Stock
ADRT.U
$23K ﹤0.01%
+2,261
New +$22.8K
CITEU
457
DELISTED
Cartica Acquisition Corp Unit
CITEU
$22K ﹤0.01%
2,119
+802
+61% +$8.2K
PSQH icon
458
PSQ Holdings
PSQH
$14.8M
$21K ﹤0.01%
138
– –
STET.U
459
DELISTED
ST Energy Transition I Ltd. SAIL securities, each consisting of one Class A ordinary share and one-half of one redeemable warrant
STET.U
$21K ﹤0.01%
2,020
– –
PFDRU
460
DELISTED
Pathfinder Acquisition Corporation Unit
PFDRU
$21K ﹤0.01%
2,360
+2,108
+837% +$21K
FMIVU
461
DELISTED
Forum Merger IV Corporation Unit
FMIVU
$20K ﹤0.01%
2,003
+200
+11% +$1.99K
CPAQU
462
DELISTED
Counter Press Acquisition Corporation Unit
CPAQU
$16K ﹤0.01%
1,527
+425
+39% +$4.32K
VSACU
463
DELISTED
Vision Sensing Acquisition Corp. Unit
VSACU
$12K ﹤0.01%
1,173
– –
ACAHU
464
DELISTED
Atlantic Coastal Acquisition Corp. Unit
ACAHU
$12K ﹤0.01%
1,236
+1,150
+1,337% +$11.4K
LIVBU
465
DELISTED
LIV Capital Acquisition Corp. II Unit
LIVBU
$11K ﹤0.01%
1,045
– –
RKTA.U
466
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$11K ﹤0.01%
1,061
+552
+108% +$5.5K
PDOT.U
467
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
$11K ﹤0.01%
1,100
– –
CLRCU
468
DELISTED
ClimateRock Unit
CLRCU
$11K ﹤0.01%
1,070
– –
FIACU
469
DELISTED
Focus Impact Acquisition Corp. Unit
FIACU
$10K ﹤0.01%
+1,019
New +$10.3K
PRPC.U
470
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$10K ﹤0.01%
950
– –
IBER.U
471
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$10K ﹤0.01%
1,000
– –
ATAQ.U
472
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
$10K ﹤0.01%
1,000
– –
PTOCU
473
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
$10K ﹤0.01%
1,039
+39
+4% +$386
CSTA.U
474
DELISTED
Constellation Acquisition Corp I Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CSTA.U
$8K ﹤0.01%
789
– –
ACACU
475
DELISTED
Acri Capital Acquisition Corp Unit
ACACU
$7K ﹤0.01%
701
+691
+6,910% +$7K
17 18
19
20 21

Similar funds

GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
VDI
Vaughan David Investments Peoria, Illinois $4.73B AUM 19.55% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
JCM
Junto Capital Management New York $4.74B AUM 27.96% 1-Year Est. Return

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.